Metronomia news
Our best wishes for 2018!
Metronomia wishes you - our customers, partners and visitors - a successful and Happy New Year 2018!
We are looking forward to continuing our successful collaboration (or start up a new one) this year.
Meet Metronomia at Clinical Operations in Oncology Europe 2017
Metronomia will participate in the Clinical Operations in Oncology Europe 2017 conference. Meet us from December 5-6 in Munich.
Read more … Meet Metronomia at Clinical Operations in Oncology Europe 2017
Meet Metronomia at Bio Europe 2017
Metronomia will participate in the Bio Europe 2017. Meet us from November 6-8 in Berlin.
Presenting at CEN-ISBS Vienna 2017
We are proud that a contribution of Metronomia statisticians was selected for an oral presentation at the Joint Conference on Biometrics & Biopharmaceutical Statistics from 28 August to 1 September 2017 in Vienna, Austria.
Sponsoring CEN-ISBS Vienna 2017
Metronomia is sponsoring the Joint Conference on Biometrics & Biopharmaceutical Statistics from 28 August to 1 September 2017 in Vienna, Austria.
Meet us at the 7th annual “Outsourcing in Clinical Trials Europe”-Conference, Booth 66, 16 – 17 Mai 2017 | Barcelona | Spain
Metronomia will be present at the 7th annual OCT Europe conference, taking place from 16 - 17th Mai 2017 in Barcelona, Spain. We are happy to meet you at booth no.66.
Upcoming Webinar: “Best practice in dose finding studies”
Metronomia warmly invites you to join our webinar series on excellence in clinical trials: On 4th of April 2017, an expert panel of Metronomia Statisticians will discuss state of the art dose finding approaches in phase I and II clinical trials:
Read more … Upcoming Webinar: “Best practice in dose finding studies”
Our best wishes for 2017!
Metronomia wishes you - our customers, partners and visitors - a successful and Happy New Year 2017!
We are looking forward to continuing our successful collaboration (or start up a new one) this year.
Phase III study in allergic rhinitis awarded
We are proud that Metronomia was awarded a large, multinational phase III study with specific immunotherapy (SIT) in seasonal allergic rhinitis by one of our international clients
Presenting at HEC 2016
Scientific presentation of Metronomia about MCP-Mod at the HEC 2016 in August in Munich.